Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: a multicenter study in Japan
- PMID: 22632442
- DOI: 10.3109/17482968.2012.678366
Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: a multicenter study in Japan
Abstract
Malnutrition in the early stage has been reported as an independent predictor of survival in amyotrophic lateral sclerosis (ALS). We analyzed retrospectively the effect of variation of body mass index (BMI) on survival in ALS patients. In total, 77 consecutive ALS patients were enrolled from nine hospitals in Japan. Reduction rate of BMI was calculated from BMI before the disease onset and at the time of the first visit to each hospital. We analyzed the correlation between BMI reduction rate and total disease duration. Results showed that the median BMI reduction rate was 2.5 per year (interquartile range 1.3-3.8). The BMI reduction rate was significantly correlated with survival length (p <0.0001). There was also a significant difference in survival between ALS patients with a BMI reduction rate ≥ and < 2.5 (Kaplan-Meier survival analysis and the log-rank test, p < 0.0001; hazard ratio by the Cox model, 2.9816). In conclusion, faster reduction of BMI at the initial stage before the first visit to hospital predicts shorter survival length also in Japanese ALS patients.
Similar articles
-
Phase angle is a prognostic factor for survival in amyotrophic lateral sclerosis.Amyotroph Lateral Scler. 2008 Oct;9(5):273-8. doi: 10.1080/17482960801925039. Amyotroph Lateral Scler. 2008. PMID: 18720089
-
Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005.J Neurol Sci. 2008 May 15;268(1-2):95-101. doi: 10.1016/j.jns.2007.11.011. Epub 2007 Dec 31. J Neurol Sci. 2008. PMID: 18164728
-
Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS.J Neurol Sci. 2010 Oct 15;297(1-2):36-9. doi: 10.1016/j.jns.2010.06.028. Epub 2010 Jul 31. J Neurol Sci. 2010. PMID: 20673675
-
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).Amyotroph Lateral Scler Other Motor Neuron Disord. 2003 Sep;4(3):191-206. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003. PMID: 13129806 Review.
-
Medications and laboratory parameters as prognostic factors in amyotrophic lateral sclerosis.Amyotroph Lateral Scler. 2008 Dec;9(6):369-74. doi: 10.1080/17482960802163614. Amyotroph Lateral Scler. 2008. PMID: 18608098 Review.
Cited by
-
Molecular Aspects of a Diet as a New Pathway in the Prevention and Treatment of Alzheimer's Disease.Int J Mol Sci. 2023 Jun 28;24(13):10751. doi: 10.3390/ijms241310751. Int J Mol Sci. 2023. PMID: 37445928 Free PMC article. Review.
-
Body Mass Index and Amyotrophic Lateral Sclerosis: A Study of US Military Veterans.Am J Epidemiol. 2017 Mar 1;185(5):362-371. doi: 10.1093/aje/kww140. Am J Epidemiol. 2017. PMID: 28158443 Free PMC article.
-
Altered TDP-43 Structure and Function: Key Insights into Aberrant RNA, Mitochondrial, and Cellular and Systemic Metabolism in Amyotrophic Lateral Sclerosis.Metabolites. 2022 Jul 29;12(8):709. doi: 10.3390/metabo12080709. Metabolites. 2022. PMID: 36005581 Free PMC article. Review.
-
Energy Balance as a Moderator of Neurologic Disease Risk and Progression.Neurotox Res. 2020 Jun;38(1):242-248. doi: 10.1007/s12640-020-00190-4. Epub 2020 Mar 25. Neurotox Res. 2020. PMID: 32215816 Free PMC article.
-
The feeding behaviour of Amyotrophic Lateral Sclerosis mouse models is modulated by the Ca2+ -activated KCa 3.1 channels.Br J Pharmacol. 2021 Dec;178(24):4891-4906. doi: 10.1111/bph.15665. Epub 2021 Oct 5. Br J Pharmacol. 2021. PMID: 34411281 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous